Me (ME), the company that popularized consumer genetic testing, announced Tuesday that it is once again exploring “strategic ...

The genetic testing company ended last year with $79.4 million and told investors it will need to raise money to fund its ...

The testing company ended last year with $79 million and told investors it will need to raise money to fund its operations ...

SUNNYVALE, Calif., Jan. 31, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics company with a mission to help ...

Founded in 2006, 23andMe seized consumer interest with its genetic-testing kits that offered customers breakdowns of their ancestry. In 2017, it started selling tests designed to help assess a ...

Founded in 2006, 23andMe built its business by asking paying customers to send samples of saliva, from which it extracts and sequences DNA to analyse for information about ancestry, family traits ...

Shares in 23andMe are currently trading at around $3.40, giving it a valuation of just under $82 million. The company went ...

23andMe aims to empower individuals with actionable insights to enhance prevention and treatment strategies. The report integrates data from genetic markers, ancestry, and birth sex to evaluate ...

Genetic testing pioneer 23andMe is looking at strategic alternatives, including a possible sale, it said Tuesday, months ...

But over 15 million people did just that with the popular genetic-testing and ancestry-tracking company 23andMe. These concerns certainly haven't been soothed by recent news out of the company.